SG190095A1 - Cosmetic composition containing gulfweed extract, sea staghorn extract, and brown seaweed extract - Google Patents
Cosmetic composition containing gulfweed extract, sea staghorn extract, and brown seaweed extract Download PDFInfo
- Publication number
- SG190095A1 SG190095A1 SG2013033550A SG2013033550A SG190095A1 SG 190095 A1 SG190095 A1 SG 190095A1 SG 2013033550 A SG2013033550 A SG 2013033550A SG 2013033550 A SG2013033550 A SG 2013033550A SG 190095 A1 SG190095 A1 SG 190095A1
- Authority
- SG
- Singapore
- Prior art keywords
- extract
- gulfweed
- brown seaweed
- skin
- cosmetic composition
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 118
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 241000199919 Phaeophyceae Species 0.000 title claims abstract description 57
- 239000002537 cosmetic Substances 0.000 title claims abstract description 37
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 230000037394 skin elasticity Effects 0.000 claims description 18
- 230000037303 wrinkles Effects 0.000 claims description 15
- 230000003712 anti-aging effect Effects 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 239000004615 ingredient Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 40
- 230000000694 effects Effects 0.000 description 27
- 238000002360 preparation method Methods 0.000 description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 230000032683 aging Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 241001474374 Blennius Species 0.000 description 8
- 102000029816 Collagenase Human genes 0.000 description 8
- 108060005980 Collagenase Proteins 0.000 description 8
- 229960002424 collagenase Drugs 0.000 description 8
- 238000004821 distillation Methods 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 7
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 230000037319 collagen production Effects 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 239000003642 reactive oxygen metabolite Substances 0.000 description 6
- 239000000783 alginic acid Substances 0.000 description 5
- 235000010443 alginic acid Nutrition 0.000 description 5
- 229920000615 alginic acid Polymers 0.000 description 5
- 229960001126 alginic acid Drugs 0.000 description 5
- 150000004781 alginic acids Chemical class 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 235000013325 dietary fiber Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 210000002510 keratinocyte Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000012228 culture supernatant Substances 0.000 description 4
- 206010033675 panniculitis Diseases 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 210000004304 subcutaneous tissue Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 108010050808 Procollagen Proteins 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- -1 skin Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- 241000206607 Porphyra umbilicalis Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 235000019625 fat content Nutrition 0.000 description 2
- PSFDQSOCUJVVGF-UHFFFAOYSA-N harman Chemical compound C12=CC=CC=C2NC2=C1C=CN=C2C PSFDQSOCUJVVGF-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- 241000196222 Codium fragile Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 241000195473 Sargassum fulvellum Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 241001261506 Undaria pinnatifida Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- SJWWTRQNNRNTPU-ABBNZJFMSA-N fucoxanthin Chemical compound C[C@@]1(O)C[C@@H](OC(=O)C)CC(C)(C)C1=C=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SJWWTRQNNRNTPU-ABBNZJFMSA-N 0.000 description 1
- AQLRNQCFQNNMJA-UHFFFAOYSA-N fucoxanthin Natural products CC(=O)OC1CC(C)(C)C(=C=CC(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C(=O)CC23OC2(C)CC(O)CC3(C)C)C)CO)C(C)(O)C1 AQLRNQCFQNNMJA-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000006016 thyroid dysfunction Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Botany (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a cosmetic composition containing gulfweed extract, seastaghorn extract, and brown seaweed extract as active ingredients, and more particularly, to a cosmetic composition which contains one or more kinds of extracts selected from the group consisting of gulfweed extract, sea staghorn extract, and brown seaweed extract as effective ingredients, and which has good antioxidant effects, improves skin resilience, and reduceswrinkles. (Figure 1)
Description
COSMETIC COMPOSITION CONTAINING GULFWEED EXTRACT, SEA STAGHORN
EXTRACT, AND BROWN SEAWEED EXTRACT
The present invention relates to a cosmetic composition containing a gulfweed extract, a sea staghorn extract and a brown seaweed extract as active ingredients, and more particularly to a cosmetic composition containing, as an active ingredient, at least one selected from the group consisting of a gulfweed extract, a sea staghorn extract and a brown seaweed extract, which have an excellent antioxidant effect and excellent effects of improving skin elasticity and reducing skin wrinkles.
The skin is composed of three layers: the outer epidermis, the middle dermis and the inner subcutaneous tissue. The skin functions to protect the body from external physical and chemical influences. Particularly, the skin regulates the evaporation of water from the body having a water content of about 65-70%. The epidermis of the skin is composed of a horny layer, a granular layer, a squamous layer, and a basal layer in order from top to bottom. The horny layer of the epidermis has a water content of about 10-20%, forms the outermost layer of the skin, and functions to inhibit the evaporation of water from the body while preventing excessive penetration of external substances (J. Invest. Dermatol. 80(Suppl.), 44-49. 1983). The dermis of the skin is composed of a papillary laver and a reticular layer. The papillary laver is made of connective tissue that includes tough collagenous fibers and elastic fibers, which makes the skin tough and elastic, and thus it plays a crucial role in skin elasticity (wrinkles). The subcutaneous tissue of the skin is a layer made of connective layer and is sometimes called the fat tissue layer. The subcutaneous tissue is mainly made of loose connective tissue distributed in the subcutaneous fat layer, and adipocytes in the subcutaneous tissue function to store heat and as a buffer.
The causes of skin aging are largely classified into two categories: intrinsic aging and extrinsic aging. Intrinsic aging occurs naturally with increasing age. Extrinsic aging refers to skin damage resulting from long-term exposure to sunlight and includes photo-aging, and aging caused by reactive oxygen species. When the horny layer is damaged by the UV radiation of sunlight, the over-proliferation of cells in the horny layer occurs, and as a result, the thickness of the horny layer increases while photo-aging occurs. Further, due to skin damage caused by UV radiation, the collagen production ability of the dermal layer decreases, and as a result, the dermal layer becomes gradually thinner so that thicker and deeper wrinkles than those caused by intrinsic aging are produced. It is well known from many studies that reactive oxygen species (ROS) are involved in skin aging. The free radical theory of aging was proposed by Harman in 1956, and according to this theory, various reactive oxygen species produced during normal metabolic processes cause cumulative oxidative damage, resulting in aging and death. A living body has the ability to protect itself against damage caused by reactive oxygen species, but the protection is not complete, and thus the body is damaged by some reactive oxygen species. This cumulative oxidative damage occurs slowly and chronically over a period of several years or throughout the life in some cases to reduce the functions of skin cells or tissues, resulting in disease and aging. As the consumer’s desire to look younger and the demand for functional cosmetic products increased, studies on cosmetic products for improving skin elasticity and reducing skin wrinkles have been actively conducted.
Generally, cosmetic products aim to keep the body clean, make the skin beautiful and attractive and protect the skin or hair from UV radiation or a dry environment to prevent aging.
Recently, with the development of industrial society and an increase in social activity, the consciousness to positively express oneself has increased, and the desire to keep the skin beautiful and healthy using cosmetic products greatly increased. Thus, skin care and makeup cosmetic products of various types and formulations have been studied and developed, and among them, cosmetic products for improving skin elasticity and reducing skin wrinkles have been recognized as the most important products.
Accordingly, various cosmetic raw materials for improving skin elasticity and reducing skin wrinkles have been developed, and natural plant-derived raw materials have recently received a great deal of attention compared to animal-derived raw materials. Extracts from seaweeds which keep vitality in an extreme marine environment and contain large amounts of good nutrients are believed to show more potent effects and have a high consumer preference. In fact, seaweeds which are used as foods are excellent sources of vitamins and minerals, and thus it is believed that, when these seaweeds are applied to the skin, the effects thereof can be transferred directly to the skin.
Accordingly, the present inventors have conducted extensive studies on the effects of seaweed extracts on the skin, and as a result, have found that a gulfweed extract, a sea staghorn extract and a brown seaweed extract have the effects of reducing oxidative stress in the skin and reducing skin wrinkles, thereby completing the present invention.
Therefore, it is an object of the present invention to provide a cosmetic composition which has an antioxidant effect and excellent effects of improving skin elasticity and reducing skin wrinkles.
In order to accomplish the above object, the present invention provides a cosmetic composition for providing antioxidant protection to the skin, improving skin elasticity and reducing skin wrinkles, the composition containing a gulfweed extract, a sea staghorn extract and a brown seaweed extract as active ingredients.
The cosmetic composition of the present invention contains a gulfweed extract, a sea staghorn extract and a brown seaweed extract, which enhance antioxidant activity in the skin and have excellent effects of improving skin elasticity and reducing skin wrinkles.
FIG. 1 is a graphic diagram showing the effects of a gulfweed extract, a sea staghorn extract and a brown seaweed extract, which are used in the present invention, on the protection of keratinocytes from UV-induced damage.
A cosmetic composition according to the present invention contains, as an active ingredient, at least one selected from the group consisting of a gulfweed extract, a sea staghorn extract and a brown seaweed extract.
Hereinafter, the present invention will be described in further detail.
Gulfweed (Sargassum fulvellum) which is used as an active ingredient in the cosmetic composition of the present invention has roots, stems and leaves, which are clearly distinguished from each other, and the roots are holdfast. Gulfweed has one main branch and grows over 1-3 m.
The stems are pillar or triangular in shape and twist. The leaves grow from the stem toward the base and twist. Also, the leaves are wooden spoon-shaped or oval shaped and have mid veins.
The upper leaves are lancet-shaped and have sawtooth-shaped protrusions at the edges, and bubbles are formed from the stem of the body. Gulfweed is deep yellowish brown in color and is distributed in the seashores in Korea. Gulfweed contains, as main components, alginic acid, chlorophyll a-c, B-carotene, fucoxanthin, laminarin and mannitol. Gulfweed has very low dietary fiber and fat contents when analyzed in an unprocessed state, but has a dietary fiber and fat content of 30% or more when analyzed in a state processed into powder. The content of dietary fiber in gulfweed is higher than the content of carbohydrates. In Korea, many species of the genus
Sargassum are used as foods and are also used for the production of alginic acid and the like in the industrial field or as fertilizers. Alginic acid is known to help in the digestive process of the stomach, help in bowel movement to reduce constipation, and is effective for the prevention of colorectal cancer. Gulfweed is effective against hypertension and osteoporosis due to its high mineral content and is effective against thyroid dysfunctions due to its high iodine content.
Sea staghorn (Codium fragile) which is used as an active ingredient in the cosmetic composition of the present invention has smooth feeling, is dark blue in color, and is plain in taste to improve the taste of Kimchi, as recorded in JaSanEoBo (the Korean fisheries science book written by the scholar Jeong Yak-Jeon), suggesting that sea staghorn has been used as a material for improving the taste of Kimchi. Sea staghorn is known as Miru in Japanese, which means a pine living in the sea. It has a height of 10-30 cm and a thickness of 1.5-3 mm, and the lower portion thereof is slightly thicker than the upper portion. The branches are split like an antler, grow straight and reach the same height to form a fan shape. The surface is soft like cotton flannel, and colorless and transparent thread-like tissues are irregularly entangled as can be seen with a microscope. Young sea staghorn has hair at the fore part, particularly the upper part, but the hair is removed with the passage of time, leaving a mark. All the parts of the body of sea staghorn are connected to each other without having a membrane between cells so that several cell nuclei are contained in one cell. Sacks containing spores are club-shaped, the length is 5-7 times the thickness, and the top is pointed. Sea staghorn has a high dietary fiber content and contains large amounts of minerals, including calcium, iron, vitamin A, vitamin C, and niacin.
Brown seaweed (Undaria pinnatifida) which is used in the cosmetic composition of the present invention is a thalloid plant whose root, stem and leaf are clearly distinguished from each other. Brown seaweed is distributed in all the coasts in Korea, but is not distributed in areas which are strongly influenced by cold and warm currents. It lives on rocks near the low-water line, but tends to live in deep water in the southern district of Korea and in shallow water in the northern district. It is collected mainly during the period from winter to spring and has the best taste during this period. It propagates during the period from spring to summer. It is main feed for ear shells and conches and is used for edible purposes in Korea, Japan, China and the like. Itis rich in dietary fiber, potassium, calcium, iodine and the like, activates metabolism and has excellent effects on postnatal care, the prevention of constipation and obesity and the supplement of iron and calcium.
Thanks to such advantages, brown seaweed has been long ago. There is a record that brown seaweed was exported to China from the Goryeo period. Goryeo Dogyeong (a book about the
Goryeo Dynasty written by a Chinese scholar} describes that “brown seaweed is frequently taken gespective of rank. It is salty in taste and smells fishy, but is good to eat if it is taken for a long period of time”. Also, Goryeosa (a compilation on the history of Goryeo) describes that King
Munjong, the | 1® king of Goryeo, granted a place for collecting brown seaweed in the year 1058.
King Chungsun, the 26" king of Goryeo, gave brown seaweed to the Fropress Dowager of the
Yuan Dynasty in the year 1301.” Also, Donguibogam (a medical encyclopedia compiled during the Joseon Kingdom) describes that brown seaweed is cold in nature, salty in taste and non- poisonous. It reduces fever, eliminates oppression, treats “Ki” and promotes urination. Dried brown seaweed contains 12.7% protein, 52% carbohydrate, 1.1% fat, 1300 mg% Ca, 140 IU vitamin A, 0.11 mg% vitamin B1, 0.14 mg% vitamin B2, 10 mg% nicotinic acid, and 15 mg% vitamin C. Brown seaweed has a high calcium content comparable to that of powdered milk, contains 100 mg% iodine and is strongly alkaline food. Also, brown seaweed contains alginic acid as a viscous substance, and the content of alginic acid is lower in the root than the leaf or the stem.
Main carotenoid pigments in brown seaweed include fucoxanthine, violaxanthine, lutein, and f3- carotene.
The gulfweed extract, sea staghorn extract and brown seaweed extract of the present invention can be prepared according to a conventional method known in the art. For example, these extracts can be prepared by distilling each of freeze-dried gulfweed, sea staghorm and brown seaweed with steam, extracting the distillation products using glycerin as a solvent, and purifying the extracts.
The cosmetic composition of the present invention contains each of the gulfweed extract, the sea staghorn extract and the brown seaweed extract in an amount of 0.001-30 wt% based on the total weight of the composition. If the content of each extract in the cosmetic composition is less than 0.001 wt%, the composition will have no distinct effect, and if the content is more than 30 wt%, an increase in the content will not lead to a distinct increase in effects.
When the cosmetic composition of the present invention contains a mixture of the gulfweed extract, the sea staghorn extract and the brown seaweed extract, the effects of providing antioxidant protection to the skin, reducing skin wrinkles and improving skin elasticity can further be increased. Also, when the cosmetic composition of the present invention contains a mixture of the gulfweed extract, the sea staghorn extract and the brown seaweed extract, the active ingredients will show synergistic effects, and thus the effects of providing antioxidant protection to the skin, reducing skin wrinkles and improving skin elasticity will be significantly increased.
The cosmetic composition for skin external application according to the present invention contains a cosmetically and skin-scientifically acceptable medium and/or base. The cosmetic composition may be provided in any form for topical application. For example, the cosmetic composition may be provided in the form of solution, gel, solid or pasty anhydrous product, oil-in- water emulsion, suspension, microemulsion, microcapsule, microgranule, or ionic (liposome) and/or non-ionic vesicle dispersion. Alternatively, it may be provided in the form of cream, skin, lotion, powder, ointment, spray, or conceal stick. In addition, the composition for skin external application according to the present invention may be prepared according to a conventional method known in the art. Further, the cosmetic composition for skin external composition according to the present invention may also be used in the form of a foam composition or an aerosol composition further containing a compressed propellant.
The cosmetic composition for skin external application according to the present invention may contain additives which are generally used in the cosmetic field or the skin science field, for example, fatty substance, organic solvent, solubilizing agent, thickener, gelling agent, softener, antioxidant, suspending agent, stabilizer, foaming agent, fragrance, surfactant, water, ionic or non- ionic emulsifying agent, filler, metal ion sequestering agent, metal ion chelating agent, preservative, vitamins, blocker, wetting agent, essential oil, dye, pigment, hydrophilic or hydrophobic activator, lipid vesicle, or other components which are generally used in the cosmetic field or the skin science field. These additives are introduced in amounts which are generally used in the cosmetic field or the skin science field.
Mode for Invention
Hereinafter, the present invention will be described in further detail with reference to examples and test examples, but the scope of the present invention is not limited to these examples.
Preparation Example 1: Preparation of gulfweed extract 1 kg of freeze-dried gulfweed was distilled with steam for 12 hours, and the distillation product was macerated in 70% glycerin at 4 °C for 7 days, and then purified.
Preparation Example 2: Preparation of sea staghorn extract 1 kg of freeze-dried sea staghorn was distilled with steam for 12 hours, and the distillation product was macerated in 70% glycerin at 4 °C for 7 days, and then purified.
Preparation Example 3: Preparation of brown seaweed 1 kg of freeze-dried brown seaweed was distilled with steam for 12 hours, and the distillation product was macerated in 70% glycerin at 4 °C for 7 days, and then purified.
Preparation Example 4: Preparation of extract of mixture of gulfweed, sea staghorn and brown seaweed
Freeze-dried gulfweed, sea staghorn and brown seaweed were mixed with each other at a weight ratio of 1:1:1 and distilled with steam for 12 hours. The distillation product was macerated in 70% glycerin at 4 °C for 7 days, and then purified.
Preparation Example 5: Preparation of extract of mixture of gulfweed and sea staghorn
Freeze-dried gulfweed and sea staghorn were mixed with each other at a weight ratio of 1:1 and distilled with steam for 12 hours. The distillation product was macerated in 70% glycerin at 4 °C for 7 days, and then purified.
Preparation Example 6: Preparation of extract of mixture of gulfweed and brown seaweed
Freeze-dried gulfweed and brown seaweed were mixed with each other at a weight ratio of 1:1 and distilled with steam for 12 hours. The distillation product was macerated in 70% glycerin at 4 °C for 7 days, and then purified.
Preparation Example 7: Preparation of extract of mixture of sea staghorn and brown seaweed
Freeze-dried sea staghorn and brown seaweed were mixed with each other at a weight ratio of 1:1 and distilled with steam for 12 hours. The distillation product was macerated in 70% glycerin at 4 °C for 7 days, and then purified.
Test Example 1: Effect on protection from UV-induced cell damage
Keratinocytes isolated from human epidermal tissue were added to each well of a 96-well cell culture plate at a density of 1x10" cells per well and attached for 24 hours. After 18 hours, the medium was removed and 50 ££ of phosphate buffered saline (PBS) was added to each well. The keratinocytes were irradiated with 30 mJ/c of UV light from a UV-B lamp (Model: F15T8, UV
B 15W, Sankyo Dennki, Japan), after which PBS was removed and 200 ££ of keratinocyte growth media (Clonetics, BioWhittaker, MD, USA) was added to each well. Then, the cells were treated with each of the gulfweed extract, sea staghorn extract, brown seaweed extract and mixed extracts prepared in Preparation Examples 1 to 7 and were cultured for 20 hours. After a specific amount of time, a suitable amount of the culture supernatant was collected and the amount of lactate dehydrogenase (LDH) indicative of cell damage was quantified for 20 hours. The amount of LDH in the culture supernatant was measured using Cytotox 96 non-radioactive cytotoxicity assay™ kit (Promega, Madison, WI, USA). The LDH secretion (%) could be obtained by calculating the value of each group relative to the vehicle control group taken as 100, and the results of the calculation are shown in FIG. 1.
As can be seen in FIG. 1, the results of comparison between the group treated with each of the gulfweed extract, the sea staghorn extract and the brown seaweed extract and the group treated with the extract of the mixture of two or more of gulfweed, sea staghorn and brown seaweed indicated that treatment with each of the gulfweed extract, the sea staghorn extract and the brown seaweed extract could somewhat inhibit the increase in LDH caused by UV-induced damage to the human keratinocytes, but treatment with the extract of the mixture of two or more of the active ingredients more significantly inhibited the increase in LDH. Particularly, the LDH level of the cells treated with the extract of the mixture of gulfweed, sea staghorn and brown seaweed was reduced to the level similar to that of the control group (vehicle) not treated with UV light.
Therefore, it was found that the gulfweed extract, sea staghorn extract and brown seaweed extract of the present invention have excellent effects of protecting skin cells from external stimuli such as UV radiation.
Examples 1 to 7 and Comparative Example 1
According to the compositions shown in Table 1 below, cream formulations of Examples 1 to 7 and Comparative Example 1 were prepared.
Table 1 (unit: wt%)
Components Example |Example [Example [Example [Example |Example|Example |Compara 1 2 3 4 5 6 7 tive
Example 1 1 |Preparation Example|1 1 2 |Preparation Example 1 2 3 |Preparation Example 1 3 4 |Preparation Example 1 4 5 |Preparation Example 1 5
Preparation Example 1 6 7 |Preparation Example 1 7 § [Puede [rae [lee [ree [lee [rae res [ies [odes o |Gycein 8 8 8 pp 8 8 8 8
Bure co 11 [Hyaluronic acid|5 5 5 5 5 5 5 5 extract 15 [caprylic/capric triglyceride
Method for preparation of cream formulations of Examples 1 to 7 and Comparative
Example 1 1) Components (1) to (12) in Table 1 above were uniformly mixed with heating to 70 °C to prepare an aqueous phase part. 2) Components (15) to (20) were uniformly mixed with heating to 70 °C to prepare an oil phase part. 3) The oil phase part of step 2) was added to the aqueous phase part of step 1) and homogeneously mixed at 7,200 rpm for 6 minutes. 4) The mixture of step 3) was cooled to room temperature.
Test Example 2: Effect on improvement in skin elasticity
In order to test the effect of improving the elasticity of human skin, the formulations of
Examples 1 to 7 and Comparative Example 1 were tested in the following manner. Each of the formulations was applied to the face of each of twenty 25-35 years old women twice (morning and evening) a day for 8 weeks, and then the effect of improving skin elasticity was measured using
Cutometer SEM 575 (C+K Electronic Co., Germany), and the results of the measurement are shown in Table 2 below. The values in Table 2 are the viscoelasticities measured by the
Cutometer SEM 575.
Table 2: Effects on improvement in skin elasticity
Effect on skin elasticity
Example 1 0.31+0.10
Example 2 0.2740.10
Example 3 0.37+0.10
Example 4 0.49+0.10
Example 5 0.33+£0.10
Example 6 0.40+0.10
Example 7 0.41+0.10
Comparative Example|0.22+0.09 1
As can be seen from the results in Table 2 above, the group treated with each of the gulfweed extract, the sea staghorn extract and the brown seaweed extract showed increased skin elasticity, and the skin elasticity of the group treated with the extract of the mixture of two or more of gulfweed, sea staghorn and brown seaweed was further improved. Particularly, the group treated with the extract of the mixture of gulfweed, sea staghorn and brown showed the highest skin elasticity.
Therefore, it was found that the gulfweed extract, sea staghorn extract and brown seaweed extract of the present invention have excellent effects of improving skin elasticity.
Test Example 3: Effects on stimulation of collagen production
For the comparison of the ability to produce collagen, a negative control (untreated) and vitamin C as a positive control were used. Using fibroblast cell line hs68, the ability to produce type 1 procollagen and the ability to inhibit collagenase synthesis were measured.
Fibroblasts were added and attached to a FALCON 48-well plate at a density of 5x10%well, and then treated with 1 ppm of each of the gulfweed extract, the sea staghorn extract, the brown seaweed extract or the mixture of two or more thereof. The cells were cultured for 24 hours, and then the production of type 1 procollagen in the culture supernatant was measured using a type 1 pN collagen EIA kit. The production of type 1 procollagen was normalized by the total amount of protein and compared between the control group and the test groups. The results of the measurement are shown in Table 3 below.
Table 3
Collagen production tamin C 27.8% increase
Extract of mixture of gulfweed and sea staghorn | 15.2% increase
Extract of mixture of gulfweed and brown | 20.4% increase seaweed
Extract of mixture of sea staghorn and brown | 19.2% increase seaweed
Extract of mixture of gulfweed, sea staghorn | 22.9% increase and brown seaweed
As can be seen from the results in Table 3 above, the group treated with each of the gulfweed extract, the sea staghorn extract and the brown seaweed extract showed increased collagen production, and the production of collagen in the group treated with the extract of the mixture of two or more of gulfweed, sea staghorn and brown seaweed was further increased.
Particularly, the group treated with the extract of the mixture of gulfweed, sea staghorn and brown showed the highest collagen production.
Therefore, it was found that the gulfweed extract, sea staghorn extract and brown seaweed extract of the present invention have excellent effects of reducing skin wrinkles by stimulating collagen production.
Test Example 4: Effect on inhibition of collagenase synthesis
In order to measure the ability to inhibit collagenase synthesis, a negative control (untreated) and retinoic acid as a positive control were used.
Fibroblasts were added and attached to a FALCON 48-well plate at a density of 5x10%well, and then irradiated with 15 mJ/cnf of UVB. Then, the cells were treated with 1 ppm of each of the gulfweed extract, the sea staghorn extract, the brown seaweed extract or the mixture of two or more thereof. The cells were cultured for 24 hours, and then the production of MMP-1 (matrix metalloproteinases-1; a kind of collagenase) in the culture supernatant was measured using an MMP-1 ELISA kit. The amount of MMP-1 was normalized by the total amount of protein, and the results of the measurement are shown in Table 4 below.
Table 4
Retinoic acid (1M) 51.6% decrease
Extract of mixture of gulfweed and sea staghorn | 23.6% decrease
Extract of mixture of gulfweed and brown | 33.1% decrease seaweed
Extract of mixture of sea staghorn and brown | 30.9% decrease seaweed
Extract of mixture of gulfweed, sea staghorn | 46.7% decrease and brown seaweed
As can be seen from the results in Table 4 above, the group treated with each of the gulfweed extract, the sea staghorn extract and the brown seaweed extract showed reduced collagenase synthesis, and the synthesis of collagenase in the group treated with the extract of the mixture of two or more of gulfweed, sea staghorn and brown seaweed was further inhibited.
Particularly, the group treated with the extract of the mixture of gulfweed, sea staghorn and brown showed the best effect on the inhibition of collagenase synthesis.
Therefore, it was found that the gulfweed extract, sea staghorn extract and brown seaweed extract of the present invention have excellent effects of reducing skin wrinkles by effectively inhibiting collagenase synthesis.
Claims (5)
- I. A cosmetic composition containing, as an active ingredient, at least one selected from the group consisting of a gulfweed extract, a sea staghorn extract and a brown seaweed extract.
- 2. The cosmetic composition of claim 1, wherein each of the gulfweed extract, the sea staghorn extract and the brown seaweed extract is contained in an amount of 0.001-30 wt% based on the total weight of the composition.
- 3. The cosmetic composition of claim 1, wherein the composition is for anti-aging.
- 4. The cosmetic composition of claim 1, wherein the composition is for improving skin elasticity.
- 5. The cosmetic composition of claim 1, wherein the composition is for reducing skin wrinkles.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100118214A KR101839013B1 (en) | 2010-11-25 | 2010-11-25 | Cosmetic composition containing SARGASSUM FULVELLUM extract, CODIUM FRAGILE extract and UNDARIA PINNATIFIDA extract |
PCT/KR2011/008910 WO2012070835A2 (en) | 2010-11-25 | 2011-11-22 | Cosmetic composition containing gulfweed extract, sea staghorn extract, and brown seaweed extract |
Publications (1)
Publication Number | Publication Date |
---|---|
SG190095A1 true SG190095A1 (en) | 2013-06-28 |
Family
ID=46146278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2013033550A SG190095A1 (en) | 2010-11-25 | 2011-11-22 | Cosmetic composition containing gulfweed extract, sea staghorn extract, and brown seaweed extract |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP6007188B2 (en) |
KR (1) | KR101839013B1 (en) |
CN (1) | CN103228262B (en) |
HK (1) | HK1186966A1 (en) |
SG (1) | SG190095A1 (en) |
WO (1) | WO2012070835A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140097865A (en) * | 2013-01-30 | 2014-08-07 | 한태준 | Cosmetic composition comprising Laver extract for anti-inflammation |
CN104288083A (en) * | 2014-09-04 | 2015-01-21 | 杨珍 | Spirulina Chinese angelica energetic skin-nourishing powder |
CN105030587B (en) * | 2015-07-07 | 2017-12-15 | 海南海润生物科技股份有限公司 | A kind of anti-aging cosmetics containing marine algae extract and preparation method thereof |
KR101893250B1 (en) | 2015-12-21 | 2018-10-04 | 부경대학교 산학협력단 | An antioxidant composition comprising the extract or fraction of Sargassum serratifolium |
KR101883543B1 (en) * | 2016-01-22 | 2018-07-30 | 테 퐁 민 인터내셔널 코., 엘티디. | An allergy-inhibiting sea grape extract, its preparation method and application thereof |
JP7278564B2 (en) * | 2018-05-31 | 2023-05-22 | 日本メナード化粧品株式会社 | Hyaluronic Acid Production Promoter, Collagen Production Promoter, MMP Inhibitor, Wrinkle Improving Agent, Pharmaceutical or Food Composition |
KR102049698B1 (en) | 2019-06-28 | 2020-01-22 | 주식회사 신세계인터코스코리아 | Cosmetic composition for improving skin conditions |
KR102564539B1 (en) * | 2022-12-16 | 2023-08-09 | 부경대학교 산학협력단 | A composition for the prevention, improvement or treatment of sleep disorders or insomnia containing Codium fragile extract |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07101871A (en) * | 1992-12-24 | 1995-04-18 | Lion Corp | Promoter for synthesis of hyaluronic acid in living body |
JP3807782B2 (en) * | 1995-06-22 | 2006-08-09 | ライオン株式会社 | Hyaluronidase inhibitor |
JP3459857B2 (en) * | 1995-09-29 | 2003-10-27 | 株式会社資生堂 | External preparation for skin |
JPH10236918A (en) * | 1997-02-21 | 1998-09-08 | Lion Corp | Percutaneous patch agent |
JP3825882B2 (en) * | 1997-05-30 | 2006-09-27 | 株式会社ノエビア | Fibroblast activator and skin external preparation containing the same |
JPH10330280A (en) * | 1997-05-30 | 1998-12-15 | Noevir Co Ltd | Promoter for producing collagen, and skin preparation for external use for preventing aging containing the same |
JP2004089158A (en) * | 2002-07-10 | 2004-03-25 | Shirako:Kk | Method for extracting oil-soluble component of seaweed and use of extract |
US20040219124A1 (en) * | 2003-05-01 | 2004-11-04 | Gupta Shyam K. | Cosmetic and Pharmaceutical Masks Based on Ion-Pair Delivery System |
JP2008239493A (en) * | 2007-03-23 | 2008-10-09 | Naris Cosmetics Co Ltd | External preparation for skin |
-
2010
- 2010-11-25 KR KR1020100118214A patent/KR101839013B1/en active IP Right Grant
-
2011
- 2011-11-22 WO PCT/KR2011/008910 patent/WO2012070835A2/en active Application Filing
- 2011-11-22 SG SG2013033550A patent/SG190095A1/en unknown
- 2011-11-22 JP JP2013540888A patent/JP6007188B2/en not_active Expired - Fee Related
- 2011-11-22 CN CN201180056083.0A patent/CN103228262B/en not_active Expired - Fee Related
-
2013
- 2013-12-30 HK HK13114372.4A patent/HK1186966A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN103228262B (en) | 2016-02-17 |
CN103228262A (en) | 2013-07-31 |
KR101839013B1 (en) | 2018-03-15 |
WO2012070835A3 (en) | 2012-09-27 |
HK1186966A1 (en) | 2014-03-28 |
KR20120056594A (en) | 2012-06-04 |
WO2012070835A2 (en) | 2012-05-31 |
JP2013543890A (en) | 2013-12-09 |
JP6007188B2 (en) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105125476B (en) | A kind of anti-wrinkle essence and preparation method thereof | |
SG190095A1 (en) | Cosmetic composition containing gulfweed extract, sea staghorn extract, and brown seaweed extract | |
CN105147591A (en) | Anti-wrinkle face cream and preparation method thereof | |
CN108143702A (en) | A kind of efficient whitening and moisturizing facial mask liquid, facial mask and preparation method thereof | |
CN102406581A (en) | Skin protecting composite with function of tightening skin | |
CN102973486B (en) | Nourishing youth-keeping facial cleanser and preparation method thereof | |
CN104027271B (en) | Emulsion and preparation method thereof | |
CN108836919B (en) | Moisturizing cosmetic composition and preparation method and application thereof | |
CN107693456A (en) | A kind of natural tea pasta frost and preparation method thereof | |
KR101312965B1 (en) | The cosmetic composition for anti-wrinkle comprising the mixture of extract of Allium cepa, Symphytum officinale, Eclipta prostrate, and Theobroma cacao | |
JP2008120761A (en) | Beauty and health food composed of shark fin extract, yolk lecithin and fermentation aged collagen (lcp) and its manufacturing method | |
CN106309340A (en) | Grapefruit juice anti-wrinkle skin care formula | |
JP2006219432A (en) | Composition having rough skin-preventing activity, cosmetic and beverage | |
CN111603426A (en) | Moisturizing mask and preparation method thereof | |
KR20200127731A (en) | Mask pack composition containing complex mixtures comprising the extraction mixture from marine plants and mask pack using the same | |
KR101985381B1 (en) | Cosmetic composition for exfoliating skin keratin comprising fruit fermentation complex made by fermenting grape, orange, apple, lemon and lime | |
CN109528536A (en) | A kind of skin care item and preparation method thereof containing choline ellagic acid salt | |
CN110179710A (en) | A kind of infant's skin cream of the ingredient containing antipollution | |
KR101901859B1 (en) | Cosmetic composition containing SARGASSUM FULVELLUM extract, CODIUM FRAGILE extract and UNDARIA PINNATIFIDA extract | |
EP2291173A2 (en) | Combination of passion flower and alkanet extracts for use in cosmetics | |
CN105168067B (en) | A kind of vigor nti-freckle Essence and preparation method thereof | |
CN109260066A (en) | A kind of whitening and spot eliminating cream | |
CN113876671A (en) | Anti-aging composition containing rape bud extract and preparation method thereof | |
CN102366396B (en) | Rejuvenating lotion | |
CN110755343A (en) | Emulsion for old people and preparation method thereof |